Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

Publication date

January 2024

DOI

10.1371/journal.pone.0294025.s014

Abstract

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

Open link

Publication date

January 2024

DOI

10.1371/journal.pone.0294025.s014

Abstract

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.</p

Extracted data

Stringhini, Silvia
Wisniak, Ania
Piumatti, Giovanni
Azman, Andrew S
Lauer, Stephen A
Baysson, Hélène
De Ridder, David
Petrovic, Dusan
Schrempft, Stephanie
Marcus, Kailing
Yerly, Sabine
Arm Vernez, Isabelle
Keiser, Olivia
Hurst, Samia
Posfay-Barbe, Klara M
Trono, Didier
Pittet, Didier
Gétaz, Laurent
Chappuis, François
Eckerle, Isabella
Vuilleumier, Nicolas
Meyer, Benjamin
Flahault, Antoine
Kaiser, Laurent
Guessous, Idris

June 2020

Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given...

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina

Luz María Rodeles
Luz María Peverengo
Romina Benítez
Nadia Benzaquen
Priscila Serravalle
Ana Karina Long
Virginia Ferreira
Agostina Daiana Benitez
Luisina Zunino
Camila Lizarraga
Miguel Hernán Vicco

June 2021

Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomati...

Neutralizing titers to live ancestral SARS-CoV-2 and Beta variant by visits stratified by dosing interval groups.

Darryl P. Leong (10348389)
Ali Zhang (10732390)
Jessica A. Breznik (14626679)
Rumi Clare (14626682)
Angela Huynh (14626685)
Maha Mushtaha (14626688)
Sumathy Rangarajan (138134)
Hannah Stacey (14626691)
Paul Y. Kim (7491026)
Mark Loeb (248712)
Judah A. Denburg (14626694)
Dominik Mertz (88663)
Zain Chagla (9946564)
Ishac Nazy (14626697)
Matthew S. Miller (10732393)
Dawn M. E. Bowdish (12231404)
MyLinh Duong (11115178)

February 2023

Data are presented as logarithmic titers (means and 95% CI) needed to inhibit 50% of infection due t...

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

January 2024

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p

Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at scheduled visits 4, 5 and 6.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

January 2024

Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at scheduled visits 4, 5 and 6.</p

Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 positive for IgG, Where N = 1884 and n = 485 for the first round and N = 1721 and n = 588 for second round respectively).

Dabesa Gobena (14564354)
Esayas Kebede Gudina (7329965)
Daniel Yilma (446954)
Tsinuel Girma (6078650)
Getu Gebre (14564357)
Tesfaye Gelanew (237184)
Alemseged Abdissa (360998)
Daba Mulleta (14564360)
Tarekegn Sarbessa (14564363)
Henok Asefa (6269636)
Mirkuzie Woldie (5565818)
Gemechu Shumi (14564366)
Birhanu Kenate (14564369)
Arne Kroidl (723934)
Andreas Wieser (172747)
Beza Eshetu (12800370)
Tizta Tilahun Degfie (14564372)
Zeleke Mekonnen (226283)

February 2023

Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...

Seroprevalence among children and in their households.

Mariam O. Fofana (13762738)
Nivison Nery Jr (3329457)
Juan P. Aguilar Ticona (10104996)
Emilia M. M. de Andrade Belitardo (13762741)
Renato Victoriano (11985821)
Rôsangela O. Anjos (13762744)
Moyra M. Portilho (13762747)
Mayara C. de Santana (13762750)
Laiara L. dos Santos (13762753)
Daiana de Oliveira (5165669)
Jaqueline S. Cruz (11210373)
M. Catherine Muenker (9471134)
Ricardo Khouri (149050)
Elsio A. Wunder Jr (13762756)
Matt D. T. Hitchings (5451638)
Olatunji Johnson (8534166)
Mitermayer G. Reis (7367444)
Guilherme S. Ribeiro (9105300)
Derek A. T. Cummings (8748789)
Federico Costa (569693)
Albert I. Ko (90448)

September 2022

(A) Age distribution of SARS-CoV-2 seronegative (median 32 years, IQR 19–46) and seropositive (media...

Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021

Stringhini, Silvia
Zaballa, María-Eugenia
Pullen, Nick
Perez-Saez, Javier
de Mestral, Carlos
Loizeau, Andréa
Lamour, Julien
Pennacchio, Francesco
Wisniak, ania
Dumont, Roxane Dina Caroline
Baysson, Hélène
Richard, Viviane Adissa
Lorthe, Elsa
Semaani, Claire
Balavoine, Jean-François
Pittet, Didier
Vuilleumier, Nicolas
Chappuis, François
Kherad, Omar
Azman, Andrew
Posfay Barbe, Klara
Kaiser, Laurent
Guessous, Idris
Specchio-COVID19 study group

January 2021

Background: Up-to-date seroprevalence estimates are critical to describe the SARS-CoV-2 immune lands...

Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up by participants’ work and home council areas.

Dike B. Ojji (2609689)
Amelia Sancilio (845432)
Gabriel L. Shedul (13191986)
Ikechukwu A. Orji (11357503)
Aashima Chopra (13192007)
Joel Abu (14439044)
Blessing Akor (11357515)
Nana Ripiye (14439047)
Funmi Akinlade (14439050)
Douglas Okoye (14439053)
Emmanuel Okpetu (14439056)
Helen Eze (13191989)
Emmanuel Odoh (14439059)
Abigail S. Baldridge (11357518)
Priya Tripathi (13192013)
Haruna Abubakar (14439062)
Abubakar M. Jamda (14439065)
Lisa R. Hirschhorn (9521029)
Thomas McDade (5133689)
Mark D. Huffman (9951961)

January 2023

Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up...

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia : a population-based study

Barchuk, Anton
Skougarevskiy, Dmitriy
Titaev, Kirill
Shirokov, Daniil
Raskina, Yulia
Novkunkskaya, Anastasia
Talantov, Petr
Isaev, Artur
Pomerantseva, Ekaterina
Zhikrivetskaya, Svetlana
Barabanova, Lubov
Volkov, Vadim

January 2021

Properly conducted serological survey can help determine infection disease true spread. This study a...

SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.

Takahashi, Saki
Peluso, Michael
Hakim, Jill
Turcios, Keirstinne
Janson, Owen
Routledge, Isobel
Busch, Michael
Hoh, Rebecca
Tai, Viva
Kelly, J
Deeks, Steven
Henrich, Timothy
Greenhouse, Bryan
Rodríguez-Barraquer, Isabel
Martin, Jeffrey

September 2023

Serosurveys are a key resource for measuring severe acute respiratory syndrome coronavirus 2 (SARS-C...

SARS-CoV-2 infection cumulative incidence rate (number of infections per person) and its 95% confidence interval during the study period, broken out by booster dose status.

Jiayue Wan (7822625)
Casey L. Cazer (5183666)
Marin E. Clarkberg (14375220)
Shane G. Henderson (14209899)
Scarlett E. Lee (14375223)
Genevive R. Meredith (8294397)
Marwan Osman (736232)
David B. Shmoys (14375226)
Peter I. Frazier (5948589)

January 2023

SARS-CoV-2 infection cumulative incidence rate (number of infections per person) and its 95% confide...

Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses:A cross-sectional cohort study in the general population

Hanssen, D. A.T.
Pagen, D. M.E.
Penders, J.
Brinkhues, S.
Dukers-Muijrers, N. H.T.M.
Hoebe, C. J.P.A.
Savelkoul, P. H.M.
van Loo, I. H.M.

November 2023

Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...

Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ≥18 years).

Puneet Misra (3721438)
Arvind Kumar Singh (8808743)
Baijayantimala Mishra (14285145)
Bijayini Behera (17616012)
Binod Kumar Patro (10151285)
Guruprasad R. Medigeshi (7446863)
Hari Shanker Joshi (17616015)
Mohammad Ahmad (563432)
Pradeep Kumar Chaturvedi (17616018)
Palanivel Chinnakali (786601)
Partha Haldar (6866432)
Mohan Bairwa (6891737)
Pradeep Kharya (17616021)
Rahul Dhodapkar (13214896)
Ramashankar Rath (7047005)
Randeep Guleria (310847)
Sanjay Kumar Rai (17616024)
Sitanshu Sekhar Kar (5439050)
Shashi Kant (3721432)
Sonali Sarkar (805160)
Subrata Baidya (17616027)
Suneeta Meena (17101863)
Suprakash Mandal (17616030)
Surekha Kishore (17616033)
Tapan Majumder (17616036)
Vivek Hada (17616039)

December 2023

Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ...

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

Bobrovitz, N
Arora, RK
Cao, C
Boucher, E
Liu, M
Donnici, C
Yanes-Lane, M
Whelan, M
Perlman-Arrow, S
Chen, J
Rahim, H
Ilincic, N
Segal, M
Duarte, N
Van Wyk, J
Yan, T
Atmaja, A
Rocco, S
Joseph, A
Penny, L
Clifton, DA
Williamson, T
Yansouni, CP
Evans, TG
Chevrier, J
Papenburg, J
Cheng, MP

January 2021

Background Many studies report the seroprevalence of severe acute respiratory syndrome coronavirus 2...

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Stringhini, Silvia
Wisniak, Ania
Piumatti, Giovanni
Azman, Andrew S
Lauer, Stephen A
Baysson, Hélène
De Ridder, David
Petrovic, Dusan
Schrempft, Stephanie
Marcus, Kailing
Yerly, Sabine
Arm Vernez, Isabelle
Keiser, Olivia
Hurst, Samia
Posfay-Barbe, Klara M
Trono, Didier
Pittet, Didier
Gétaz, Laurent
Chappuis, François
Eckerle, Isabella
Vuilleumier, Nicolas
Meyer, Benjamin
Flahault, Antoine
Kaiser, Laurent
Guessous, Idris

June 2020

Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given...

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina

Luz María Rodeles
Luz María Peverengo
Romina Benítez
Nadia Benzaquen
Priscila Serravalle
Ana Karina Long
Virginia Ferreira
Agostina Daiana Benitez
Luisina Zunino
Camila Lizarraga
Miguel Hernán Vicco

June 2021

Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomati...

Neutralizing titers to live ancestral SARS-CoV-2 and Beta variant by visits stratified by dosing interval groups.

Darryl P. Leong (10348389)
Ali Zhang (10732390)
Jessica A. Breznik (14626679)
Rumi Clare (14626682)
Angela Huynh (14626685)
Maha Mushtaha (14626688)
Sumathy Rangarajan (138134)
Hannah Stacey (14626691)
Paul Y. Kim (7491026)
Mark Loeb (248712)
Judah A. Denburg (14626694)
Dominik Mertz (88663)
Zain Chagla (9946564)
Ishac Nazy (14626697)
Matthew S. Miller (10732393)
Dawn M. E. Bowdish (12231404)
MyLinh Duong (11115178)

February 2023

Data are presented as logarithmic titers (means and 95% CI) needed to inhibit 50% of infection due t...

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

January 2024

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p

Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at scheduled visits 4, 5 and 6.

Stephan Gehring (1443118)
Frank Kowalzik (12433533)
Omar Okasha (384203)
Tobias Engelmann (17873655)
Daniel Schreiner (17873658)
Christian Jensen (3507365)
Aline Mähringer-Kunz (8394255)
Wendy Hartig-Merkel (17873661)
Thao Mai Phuong Tran (17873664)
Cornelia Oostvogels (17873667)
Thomas Verstraeten (2266663)

January 2024

Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at scheduled visits 4, 5 and 6.</p

Dabesa Gobena (14564354)
Esayas Kebede Gudina (7329965)
Daniel Yilma (446954)
Tsinuel Girma (6078650)
Getu Gebre (14564357)
Tesfaye Gelanew (237184)
Alemseged Abdissa (360998)
Daba Mulleta (14564360)
Tarekegn Sarbessa (14564363)
Henok Asefa (6269636)
Mirkuzie Woldie (5565818)
Gemechu Shumi (14564366)
Birhanu Kenate (14564369)
Arne Kroidl (723934)
Andreas Wieser (172747)
Beza Eshetu (12800370)
Tizta Tilahun Degfie (14564372)
Zeleke Mekonnen (226283)

February 2023

Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...

Seroprevalence among children and in their households.

Mariam O. Fofana (13762738)
Nivison Nery Jr (3329457)
Juan P. Aguilar Ticona (10104996)
Emilia M. M. de Andrade Belitardo (13762741)
Renato Victoriano (11985821)
Rôsangela O. Anjos (13762744)
Moyra M. Portilho (13762747)
Mayara C. de Santana (13762750)
Laiara L. dos Santos (13762753)
Daiana de Oliveira (5165669)
Jaqueline S. Cruz (11210373)
M. Catherine Muenker (9471134)
Ricardo Khouri (149050)
Elsio A. Wunder Jr (13762756)
Matt D. T. Hitchings (5451638)
Olatunji Johnson (8534166)
Mitermayer G. Reis (7367444)
Guilherme S. Ribeiro (9105300)
Derek A. T. Cummings (8748789)
Federico Costa (569693)
Albert I. Ko (90448)

September 2022

(A) Age distribution of SARS-CoV-2 seronegative (median 32 years, IQR 19–46) and seropositive (media...

Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021

Stringhini, Silvia
Zaballa, María-Eugenia
Pullen, Nick
Perez-Saez, Javier
de Mestral, Carlos
Loizeau, Andréa
Lamour, Julien
Pennacchio, Francesco
Wisniak, ania
Dumont, Roxane Dina Caroline
Baysson, Hélène
Richard, Viviane Adissa
Lorthe, Elsa
Semaani, Claire
Balavoine, Jean-François
Pittet, Didier
Vuilleumier, Nicolas
Chappuis, François
Kherad, Omar
Azman, Andrew
Posfay Barbe, Klara
Kaiser, Laurent
Guessous, Idris
Specchio-COVID19 study group

January 2021

Background: Up-to-date seroprevalence estimates are critical to describe the SARS-CoV-2 immune lands...

Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up by participants’ work and home council areas.

Dike B. Ojji (2609689)
Amelia Sancilio (845432)
Gabriel L. Shedul (13191986)
Ikechukwu A. Orji (11357503)
Aashima Chopra (13192007)
Joel Abu (14439044)
Blessing Akor (11357515)
Nana Ripiye (14439047)
Funmi Akinlade (14439050)
Douglas Okoye (14439053)
Emmanuel Okpetu (14439056)
Helen Eze (13191989)
Emmanuel Odoh (14439059)
Abigail S. Baldridge (11357518)
Priya Tripathi (13192013)
Haruna Abubakar (14439062)
Abubakar M. Jamda (14439065)
Lisa R. Hirschhorn (9521029)
Thomas McDade (5133689)
Mark D. Huffman (9951961)

January 2023

Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up...

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia : a population-based study

Barchuk, Anton
Skougarevskiy, Dmitriy
Titaev, Kirill
Shirokov, Daniil
Raskina, Yulia
Novkunkskaya, Anastasia
Talantov, Petr
Isaev, Artur
Pomerantseva, Ekaterina
Zhikrivetskaya, Svetlana
Barabanova, Lubov
Volkov, Vadim

January 2021

Properly conducted serological survey can help determine infection disease true spread. This study a...

SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.

Takahashi, Saki
Peluso, Michael
Hakim, Jill
Turcios, Keirstinne
Janson, Owen
Routledge, Isobel
Busch, Michael
Hoh, Rebecca
Tai, Viva
Kelly, J
Deeks, Steven
Henrich, Timothy
Greenhouse, Bryan
Rodríguez-Barraquer, Isabel
Martin, Jeffrey

September 2023

Serosurveys are a key resource for measuring severe acute respiratory syndrome coronavirus 2 (SARS-C...

SARS-CoV-2 infection cumulative incidence rate (number of infections per person) and its 95% confidence interval during the study period, broken out by booster dose status.

Jiayue Wan (7822625)
Casey L. Cazer (5183666)
Marin E. Clarkberg (14375220)
Shane G. Henderson (14209899)
Scarlett E. Lee (14375223)
Genevive R. Meredith (8294397)
Marwan Osman (736232)
David B. Shmoys (14375226)
Peter I. Frazier (5948589)

January 2023

SARS-CoV-2 infection cumulative incidence rate (number of infections per person) and its 95% confide...

Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses:A cross-sectional cohort study in the general population

Hanssen, D. A.T.
Pagen, D. M.E.
Penders, J.
Brinkhues, S.
Dukers-Muijrers, N. H.T.M.
Hoebe, C. J.P.A.
Savelkoul, P. H.M.
van Loo, I. H.M.

November 2023

Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...

Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ≥18 years).

Puneet Misra (3721438)
Arvind Kumar Singh (8808743)
Baijayantimala Mishra (14285145)
Bijayini Behera (17616012)
Binod Kumar Patro (10151285)
Guruprasad R. Medigeshi (7446863)
Hari Shanker Joshi (17616015)
Mohammad Ahmad (563432)
Pradeep Kumar Chaturvedi (17616018)
Palanivel Chinnakali (786601)
Partha Haldar (6866432)
Mohan Bairwa (6891737)
Pradeep Kharya (17616021)
Rahul Dhodapkar (13214896)
Ramashankar Rath (7047005)
Randeep Guleria (310847)
Sanjay Kumar Rai (17616024)
Sitanshu Sekhar Kar (5439050)
Shashi Kant (3721432)
Sonali Sarkar (805160)
Subrata Baidya (17616027)
Suneeta Meena (17101863)
Suprakash Mandal (17616030)
Surekha Kishore (17616033)
Tapan Majumder (17616036)
Vivek Hada (17616039)

December 2023

Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ...

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

Bobrovitz, N
Arora, RK
Cao, C
Boucher, E
Liu, M
Donnici, C
Yanes-Lane, M
Whelan, M
Perlman-Arrow, S
Chen, J
Rahim, H
Ilincic, N
Segal, M
Duarte, N
Van Wyk, J
Yan, T
Atmaja, A
Rocco, S
Joseph, A
Penny, L
Clifton, DA
Williamson, T
Yansouni, CP
Evans, TG
Chevrier, J
Papenburg, J
Cheng, MP

January 2021

Background Many studies report the seroprevalence of severe acute respiratory syndrome coronavirus 2...

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Stringhini, Silvia
Wisniak, Ania
Piumatti, Giovanni
Azman, Andrew S
Lauer, Stephen A
Baysson, Hélène
De Ridder, David
Petrovic, Dusan
Schrempft, Stephanie
Marcus, Kailing
Yerly, Sabine
Arm Vernez, Isabelle
Keiser, Olivia
Hurst, Samia
Posfay-Barbe, Klara M
Trono, Didier
Pittet, Didier
Gétaz, Laurent
Chappuis, François
Eckerle, Isabella
Vuilleumier, Nicolas
Meyer, Benjamin
Flahault, Antoine
Kaiser, Laurent
Guessous, Idris

June 2020

Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given...

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina

Luz María Rodeles
Luz María Peverengo
Romina Benítez
Nadia Benzaquen
Priscila Serravalle
Ana Karina Long
Virginia Ferreira
Agostina Daiana Benitez
Luisina Zunino
Camila Lizarraga
Miguel Hernán Vicco

June 2021

Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomati...

Neutralizing titers to live ancestral SARS-CoV-2 and Beta variant by visits stratified by dosing interval groups.

Darryl P. Leong (10348389)
Ali Zhang (10732390)
Jessica A. Breznik (14626679)
Rumi Clare (14626682)
Angela Huynh (14626685)
Maha Mushtaha (14626688)
Sumathy Rangarajan (138134)
Hannah Stacey (14626691)
Paul Y. Kim (7491026)
Mark Loeb (248712)
Judah A. Denburg (14626694)
Dominik Mertz (88663)
Zain Chagla (9946564)
Ishac Nazy (14626697)
Matthew S. Miller (10732393)
Dawn M. E. Bowdish (12231404)
MyLinh Duong (11115178)

February 2023

Data are presented as logarithmic titers (means and 95% CI) needed to inhibit 50% of infection due t...

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.

Abstract

Extracted data

Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified by age/sex/comorbidities and vaccine uptake.

Abstract

Extracted data

Related items

Related items